rs768057735
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 1P and 2B. PP2BP4_Moderate
The NM_001267550.2(TTN):āc.66187G>Cā(p.Val22063Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000552 in 1,612,678 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_001267550.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTN | NM_001267550.2 | c.66187G>C | p.Val22063Leu | missense_variant | 315/363 | ENST00000589042.5 | NP_001254479.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTN | ENST00000589042.5 | c.66187G>C | p.Val22063Leu | missense_variant | 315/363 | 5 | NM_001267550.2 | ENSP00000467141.1 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152026Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000649 AC: 16AN: 246544Hom.: 0 AF XY: 0.0000747 AC XY: 10AN XY: 133854
GnomAD4 exome AF: 0.0000568 AC: 83AN: 1460652Hom.: 0 Cov.: 32 AF XY: 0.0000550 AC XY: 40AN XY: 726626
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152026Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74234
ClinVar
Submissions by phenotype
not provided Uncertain:4
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Feb 12, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 05, 2015 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 12, 2017 | A variant of uncertain significance has been identified in the TTN gene. While the V20422L variant has not been published as pathogenic or been reported as benign to our knowledge, it has been classified as a variant of uncertain significance (reported as V22063L using alternate nomenclature) by another clinical laboratory in ClinVar (SCV000228406.3; Landrum et al., 2016). This variant is observed in 12/65,868 (0.02%) alleles from individuals of European ancestry in the ExAC dataset (Lek et al., 2016; Exome Variant Server). The V20422L variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position where amino acids with similar properties to valine are tolerated across species. In silico analysis is inconsistent in its predictions as to whether or not the missense substitution is damaging to the protein structure/function. Nevertheless, the V20422L variant is predicted to strengthen a potential downstream cryptic splice acceptor site, which may lead to abnormal gene splicing. Guanine (G) is not conserved across species but only purines are observed as wild-type at this position. In the absence of functional mRNA studies, the physiological consequence of this variant cannot be precisely determined. - |
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 05, 2018 | - - |
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1838244:Tibial muscular dystrophy;C1858763:Dilated cardiomyopathy 1G;C1861065:Hypertrophic cardiomyopathy 9;C1863599:Myopathy, myofibrillar, 9, with early respiratory failure;C2673677:Early-onset myopathy with fatal cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 14, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at